Child Injured in COVID Jab Trial Is Ignored
When Stephanie de Garay allowed her three children to sign up for Pfizer's COVID-19 clinical trial for 12- to 15-year-olds, she assumed the worst that could happen was
anaphylactic shock — and in that case, they'd be treated with an EpiPen and be fine. From her daughter's perspective, the trial was